SCOPOLAMINE ATTENUATES HALOPERIDOL-INDUCED C-FOS EXPRESSION IN THE STRIATUM

被引:45
作者
GUO, N [1 ]
ROBERTSON, GS [1 ]
FIBIGER, HC [1 ]
机构
[1] UNIV BRITISH COLUMBIA,DEPT PSYCHIAT,DIV NEUROL SCI,VANCOUVER V6T 1Z3,BC,CANADA
关键词
CATALEPSY; C-FOS; HALOPERIDOL; SCOPOLAMINE; STRIATUM;
D O I
10.1016/0006-8993(92)91358-L
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Haloperidol increases the expression of Fos, the protein product of the proto-oncogene c-fos, in some parts of the central nervous system. Haloperidol also produces catalepsy in rodents and extrapyramidal side effects in humans, both of which are reduced by muscarinic receptor antagonists. In order to gain insight into the neurochemical and neuroanatomical substrates of haloperidol-induced catalepsy we examined the effects of the muscarinic receptor antagonist scopolamine on haloperidol-induced Fos expression in the striatum, nucleus accumbens and lateral septal nucleus. At a dose that reduced the cataleptic effect of haloperidol, scopolamine decreased the neuroleptic-induced Fos expression in the striatum and lateral septal nucleus but not the nucleus accumbens. These results indicate that haloperidol may increase c-fos expression in medium spiny striatal neurons indirectly by enhancing striatal acetylcholine release. They are also consistent with the hypothesis that neuroleptic-induced increases in striatal c-fos expression are predictive of extrapyramidal side effects produced by these compounds.
引用
收藏
页码:164 / 167
页数:4
相关论文
共 29 条
[1]  
ARNT J, 1986, ACTA PHARMACOL TOX, V59, P319
[2]   DIFFERENTIAL REVERSAL BY SCOPOLAMINE AND THIP OF THE ANTISTEREOTYPIC AND CATALEPTIC EFFECTS OF NEUROLEPTICS [J].
ARNT, J ;
CHRISTENSEN, AV .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 69 (01) :107-111
[3]  
BALDESSARINI RJ, 1990, PHARMACOL BASIS THER, P383
[4]  
BERTORELLI R, 1990, J NEUROCHEM, V54, P214
[5]  
Brown JH., 1990, PHARM BASIS THERAPEU, V8, P150
[6]   SCOPOLAMINE MODULATES APOMORPHINE-INDUCED BEHAVIOR IN RATS TREATED WITH HALOPERIDOL OR SCH-23390 [J].
BUTKERAIT, P ;
FRIEDMAN, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 148 (02) :269-272
[7]  
CEDARBAUM JM, 1990, PHARMACOL BASIS THER, P463
[8]  
CONSOLO S, 1987, CELLULAR MOL BASIS C, P256
[9]   CHOLINERGIC MODIFICATION OF ABNORMAL INVOLUNTARY MOVEMENTS INDUCED IN GUINEA-PIG BY INTRASTRIATAL DOPAMINE [J].
COSTALL, B ;
NAYLOR, RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (04) :273-275
[10]   DOPAMINERGIC REGULATION OF STRIATAL CHOLINERGIC INTERNEURONS - AN INVIVO MICRODIALYSIS STUDY [J].
DAMSMA, G ;
DEBOER, P ;
WESTERINK, BHC ;
FIBIGER, HC .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1990, 342 (05) :523-527